Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ...
GDMT (guideline-directed medical therapy) is a long-term medication plan for patients with heart failure. Learn the order of ...
There’s encouraging news for people with heart conditions, particularly those dealing with coronary artery disease—a ...
A soon-to-be-published study analyzed more than 6 million patient records to help support a growing link between heart and ...
Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously difficult ...
And more. 1. AstraZeneca pays CSPC $100M for preclinical heart disease drug, teeing up combos and Lilly rivalry AstraZeneca ...
Ascension Sacred Heart Pensacola is expanding its cardiovascular services by adding new FDA-approved technology to treat ...
Baptist Memorial Hospital-North Mississippi treated its first patient using new transcatheter aortic valve replacement ...